lung Archives - Journal for Clinical Studies

Current Edition

Regional News

Novartis aims to keep canakinumab’s early lung cancer hopes alive despite metastatic failure

When Novartis failed in an attempt to repurpose Ilaris for metastatic non-small cell lung cancer (NSCLC), the Swiss pharma played up signs that it said supported cont...

13 April 2022 Regional News cancer | cell

Continue Reading →

Europe

Cancer Research UK tests first of its kind vaccine to treat lung cancer

A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer (NSCLC), under a collaboration agreement...

13 June 2018 Europe cancer | first

Continue Reading →

Europe

AstraZeneca won’t submit lung drug for COPD after 2nd study miss

AstraZeneca no longer plans to seek approval of its new respiratory biologic Fasenra in chronic obstructive pulmonary disease (COPD) after the second of two Phase...

6 June 2018 Europe 2nd | AstraZeneca

Continue Reading →

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Rare Disease Ebook

Decentralised Clinical Trials in The EU

RWS – eBook

It’s All About Stem Cells

Covid-19

Current Edition

Novartis aims to keep canakinumab’s early lung cancer hopes alive despite metastatic failure

Cancer Research UK tests first of its kind vaccine to treat lung cancer

AstraZeneca won’t submit lung drug for COPD after 2nd study miss

Journal for Clinical Studies